Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?
Título
Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?
Autor
Antonio Vitiello, Francesco Ferrara, Raffaele La Porta
Fecha
2021
Identificador
10.1007/s11845-020-02482-2
Fuente
Irish journal of medical science
Colección
Citación
Antonio Vitiello, Francesco Ferrara, Raffaele La Porta, “Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?,” SOCICT Open, consulta 18 de abril de 2026, https://socictopen.socict.org/items/show/8501.
Position: 18613 (16 views)